Skip to Content

No significant impact of plasma cfDNA levels on ctDNA detection rates across different MRD in patients with colorectal cancer

A study presented at ASCO GI has examined the link between post-operative levels of circulating cell-free DNA (cfDNA) and ctDNA positivity in patients with surgically removed stage I-III colorectal cancer. Stacey A. Cohen of the University of Washington/ Fred Hutchinson Cancer Center in Seattle, USA, presents and discusses the study’s findings in this MEDtalk.

Stacey Cohen

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top